Últimas noticias sobre Turnstone Biologics (NASDAQ:TSBX) Bolsa

Turnstone Biologics

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Turnstone Biologics Corp

Pfizer Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) released topline results from the Phase 3 BASIS study evaluating Hympavzi (marstacimab) for adults and adolescents living with hemophilia A or B with inhibitors.
Phase 3 BASIS study in patients without inhibitors supported the FDA approval of <a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41310468/fda-approves-pfizers-second-hemophilia-drug-with-six-months" rel="noreferrer noopener">Hympavzi in October 2024</a>.
The study met the primary endpoint and key secondary bleeding endpoints, demonstrating the superiority of once-weekly subcutaneous Hympavzi in improving key bleeding outcomes compared to on-demand treatment in a patient population where less burdensome treatment <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/b46111475/pfizer-announces-positive-topline-phase-3-results-for-hympavzi-in-hemophilia-a-or-b-with-inhibitor" rel="noreferrer noopener">approaches are needed</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44560065/fda-approves-sanofis-hemophilia-drug" rel="noreferrer noopener">FDA Approves Sanofi&#8217;s Hemophilia Drug</a>
The BASIS trial demonstrated that prophylactic treatment with Hympavzi resulted in a statistically significant and clinically relevant reduction in annualized bleeding rate (ABR) of treated bleeds in people with severe hemophilia A or B with inhibitors.
Forty-eight people living with hemophilia were treated with Hympavzi during 12 months versus an on-demand intravenous regimen with bypassing agents, administered as part of usual care in the six-month lead-in period.
Hympavzi was superior to on-demand treatment with a 93% reduction in ABR over 12 months (ABR 1.39 vs ABR on-demand 19.78; p &lt; 0.0001).
The superiority of Hympavzi was also demonstrated across all bleeding-related secondary endpoints, spontaneous bleeds, joint bleeds, target joint bleeds, and total bleeds, Pfizer announced on Thursday.
Hympavzi was generally well-tolerated, consistent with the non-inhibitor cohort of the BASIS study and Phase 1/2 results. No deaths or thromboembolic events were reported.
Analyses of the full Phase 3 dataset from the inhibitor cohort of the BASIS study are ongoing, and additional data will be presented at upcoming medical meetings.
Hympavzi&#8217;s mechanism of action is differentiated from those of FVIII and FIX replacement treatments. Instead of replacing missing or insufficient clotting factors, Hympavzi is intentionally designed to target tissue factor pathway inhibitor (TFPI), one of the body&#8217;s natural mechanisms that inhibits the initiation of blood clotting.
By targeting the Kunitz 2 domain of TFPI, Hympavzi may help re-establish balance between bleeding and blood clot formation. Its goal is to offer a combination of bleed protection, good tolerability, and straightforward administration.
Pfizer plans to discuss these data with regulatory authorities to initiate regulatory filings for Hympavzi for hemophilia patients with inhibitors.
Price Action: PFE stock is trading lower by 0.05% to $24.25 at last check Thursday
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/46109624/rfk-jr-overhauls-cdc-vaccine-panel-sparking-expert-backlash-boycott-from-top-medical-group" target="_blank" rel="noreferrer noopener">RFK Jr. Overhauls CDC Vaccine Panel, Sparking Expert Backlash, Boycott From Top Medical Group</a></li>
</ul>
Photo by ShU studio via Shutterstock

Biotech

Large Cap

News

Health Care

General

Pfizer Seeks Label Expansion For Hemophilia Drug After Promising Data

ENFLONSIA is the first and only RSV preventive option for administration to infants using the same dose regardless of weight
Ordering will begin in July, with shipments delivered before the start of the 2025-2026 RSV season
Merck (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>), known as MSD outside of the United States and Canada, today announced the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend ENFLONSIA&#x2122; (clesrovimab-cfor) as an option for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in infants younger than 8 months of age who are born during or entering their first RSV season. The ACIP also voted to include ENFLONSIA in the Vaccines for Children Program—an important step in ensuring broad access to this preventive option for infants.
ENFLONSIA is a preventive, long-acting monoclonal antibody (mAb) designed to provide direct, rapid and durable protection through 5 months, a typical RSV season, with the same dose regardless of weight. A typical RSV season usually spans autumn to spring of the next year.
ENFLONSIA should not be administered to infants with a history of serious hypersensitivity reactions, including anaphylaxis, to any component of ENFLONSIA.
The U.S. Food and Drug Administration (FDA) <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.merck.com%2Fnews%2Fu-s-fda-approves-mercks-enflonsia-clesrovimab-cfor-for-prevention-of-respiratory-syncytial-virus-rsv-lower-respiratory-tract-disease-in-infants-born-during-or-entering-their-fir%2F&amp;esheet=54282813&amp;newsitemid=20250626825962&amp;lan=en-US&amp;anchor=approved&amp;index=1&amp;md5=1cf4781dff86794fbb9b489189f8d701">approved</a> ENFLONSIA earlier this month based on clinical data from the Phase 2b/3 CLEVER and Phase 3 SMART trials. Merck plans to make ENFLONSIA available for ordering by physicians and health care administrators in July 2025, with shipments to be delivered before the start of the 2025-2026 RSV season.
The ACIP's recommendation for ENFLONSIA is provisional and will be official once reviewed and finalized by the CDC Director or the Health and Human Services Secretary (in the absence of a CDC Director).

U.S. CDC ACIP Recommends Use Of Merck's ENFLONSIA For Prevention Of RSV Lower Respiratory Tract Disease In Infants Younger Than 8 Months Of Age Born During Or Entering Their First RSV Season

WIIM

COIN

Coinbase shares are trading higher after Oppenheimer maintained an Outperform rating and raised itsprice target from $293 to $395.

Muted PC and phone demand continues to weigh on memory chip pricing, prompting Bank of America Securities to maintain a Neutral rating on Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), even as the company posts blowout earnings and bullish guidance.
Analyst Vivek Arya maintained Micron Technology with a Neutral and <a href="https://www.benzinga.com/quote/MU/analyst-ratings" target="_blank" rel="noreferrer noopener">raised the price target</a> from $84 to $140 on Thursday.
Micron reported <a target="_blank" href="https://www.benzinga.com/markets/earnings/25/06/46104401/micron-q3-earnings-revenue-eps-beat-estimates-data-center-revenue-guidance-ai-demand" rel="noreferrer noopener">third-quarter revenue</a> of $9.3 billion, up roughly 16%, topping the&nbsp;consensus estimate of $8.87 billion. The company reported third-quarter adjusted earnings of $1.91 per share, beating analyst estimates of $1.60 per share.
Also Read: <a href="https://www.benzinga.com/markets/tech/25/06/45906594/micron-and-trump-announce-200-billion-us-chip-expansion-plan-aiming-to-create-90k-jobs" target="_blank" rel="noreferrer noopener">Micron And Trump Announce $200-Billion US Chip Expansion Plan, Aiming To Create 90K Jobs</a>
Micron expects fourth-quarter revenue of $10.7 billion, plus or minus $300 million, versus estimates of $9.88 billion. The company anticipates fourth-quarter adjusted earnings of $2.50 per share, plus or minus 15 cents, versus estimates of $2.01 per share.
Micron Technology is the last remaining pure-play U.S.-based memory company and is the third-largest supplier of memory chips including Dynamic Random Access Memory (DRAM), Not AND (NAND). Micron&#8217;s chips support disruptive trends across artificial intelligence, 5G, machine learning, and autonomous vehicles, as per Arya.
The rerating reflected improved DRAM outlook and continued <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/45867716/micron-ships-advanced-hbm4-memory-to-fuel-next-generation-ai" rel="noreferrer noopener">High Bandwidth Memory</a> (HBM) ramp, Arya noted.
According to the analyst, Micron now expects the fiscal fourth-quarter gross margin to be 42.0%, above the fiscal third-quarter&#8217;s guided 36.5%, and the fiscal first-quarter gross margin could expand further.
Arya attributed the gross margin beat to a robust pricing environment and an improving product mix.
Importantly, management expects to exit fiscal 2025 with tight DRAM inventories, significantly reduced NAND inventories, and overall company inventory near the target 120-day level, per the analyst, a substantial sequential improvement.
On the AI side, Micron&#8217;s HBM opportunities continue to expand, now shipping HBM3e 12-high to 4 customers (Graphics Processing Unit (GPU) or Application-Specific Integrated Circuit (ASIC), and the 12-high will likely crossover 8-high by the fiscal fourth-quarter. At 20-25% share of the $35 billion calendar 2025 Total Addressable Market (TAM), Arya expects Micron HBM to reach $2.4-2.5 billion exiting the fiscal first quarter.
Overall, the analyst raised calendar 2025-27E sales by 4-6% and EPS by 13-23%. However, Arya reiterated Neutral as NAND pricing remains uncertain and startup cost headwinds to gross margins remain into calendar 2026, limiting visibility beyond the near term. 
Arya projected fourth-quarter sales of $10.71 billion (prior $9.83 billion) and adjusted EPS of $2.50 (prior $1.82).
Price Action: MU stock is trading lower by 1.19% to $125.70 at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/46081371/which-small-and-mid-cap-chip-stocks-are-set-for-big-gains" target="_blank" rel="noreferrer noopener">Which Small And Mid-Cap Chip Stocks Are Set For Big Gains?</a></li>
</ul>

Price Target

Reiteration

Analyst Ratings

Tech

Trading Ideas

Micron Earnings Soar, But Weak PC And Phone Demand Keep It Grounded

Goldman Sachs analyst Susan Maklari maintains Worthington Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOR#NYSE">WOR</a>) with a Sell and raises the price target from $44 to $50.

Goldman Sachs Maintains Sell on Worthington Enterprises, Raises Price Target to $50

Converting a traditional IRA to a Roth IRA is often presented as a smart move — especially if you expect your taxes to go up later. But as one 77-year-old listener named Lily recently found out, not everyone agrees. And even <a href="https://www.benzinga.com/personal-finance/management/25/06/45986996/suze-orman-urges-americans-to-take-a-break-this-summer-even-if-they-cant-afford-to-travel">Suze Orman</a>, a longtime advocate of Roth IRAs, may surprise some fans with her take on the matter.
<h2 class="wp-block-heading">The Common Assumption: Lower Taxes in Retirement</h2>
Lily wrote into Orman's "<a href="https://omny.fm/shows/suze-ormans-women-and-money/ask-kt-suze-anything-i-don-t-trust-my-husband-with-money-what-should-i-do">Women &amp; Money</a>" podcast with a question that many retirees might relate to. Her friends, also in their late 60s and early 70s, had warned her that converting her traditional IRA to a Roth was a mistake.
Don't Miss:
<ul class="wp-block-list">
<li>GoSun's breakthrough rooftop EV charger already has 2,000+ units reserved —<a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor"> become an investor in this $41.3M clean energy brand today</a>.</li>
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market.<a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment"> Back a bold new approach to cancer treatment with high-growth potential.</a></li>
</ul>
Their reasoning? "Let our adult kids pay the taxes," Lily quoted them as saying. They believed they'd be in a lower tax bracket in retirement — but as Lily discovered, that assumption didn't hold up.
"We&#8217;re in a much higher tax bracket than when we were younger," she said.
Orman jumped in immediately, calling that the most important point. "If you buy this myth that when you get older, you&#8217;re going to be in a lower tax bracket, I&#8217;ve got a bridge to sell you," she said.&nbsp;
Given the national debt and future tax uncertainty, Orman has long <a href="https://www.benzinga.com/personal-finance/25/04/44885154/suze-orman-why-you-should-transfer-your-401k-or-403b-into-a-roth-ira-when-you-leave-a-job">encouraged Roth conversions</a> to lock in today's tax rates.
Trending: This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, with minimum investments as low as $100</a>.
<h2 class="wp-block-heading">Why Orman Says "Not Now" for Lily</h2>
Still, Orman's advice took a turn.
Despite her general support for Roth IRAs, she advised Lily not to continue converting her remaining $500,000 in traditional IRA funds.
At age 77, Lily is already in a high tax bracket — 30%. Converting more would push her even higher, resulting in a larger tax bill today without enough time to make up for it through future growth.
"The only people that will not benefit from you converting now will be your kids," Orman said. And in this case, Lily's four children are in the 12% to 22% tax brackets — lower than Lily's.
From a tax-planning perspective, Orman says it makes more sense for Lily to keep her funds in the <a href="https://www.benzinga.com/personal-finance/25/05/45587754/i-contributed-after-tax-amounts-to-a-pre-tax-ira-can-i-withdraw-those-contributions-to-open-a-roth-account-heres-what-suze-orman-says">traditional IRA</a> and allow her children to inherit it. While they'll owe income taxes when they withdraw the money, they'll likely pay less overall than Lily would pay now by converting.
<h2 class="wp-block-heading">What Lily And Others Can Do Instead</h2>
Instead of converting more to a Roth, Orman advised Lily to focus on living off the distributions she already needs to take from her traditional IRA. She also suggested using income from other investments to cover living expenses, if possible.
For retirees in a similar position — already in a high tax bracket and nearing or past age 70 — it may not make financial sense to pursue large Roth conversions.
Instead, smaller strategic withdrawals, timing, and estate planning may offer better outcomes for both the retiree and their heirs.
<h2 class="wp-block-heading">The Bottom Line</h2>
While Roth IRAs remain a powerful tool, they're not one-size-fits-all. As Orman made clear, age, tax bracket, and legacy goals all matter. For Lily, the best move might be to leave things as they are — and trust that her kids will be okay paying a little tax down the road.
See Next
<ul class="wp-block-list">
<li>$100k in assets? Maximize your retirement and cut down on taxes:<a href="https://www.benzinga.com/money/wideradvisor-retirement-planning"> Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $100.</a></li>
</ul>

Personal Finance

'My Retired Friends Say I'm A Fool For Converting My Traditional IRAs To A Roth' — Suze Orman's  Reply May Surprise You

<a href="https://x.com/FAA_Chris/status/1938290132525703308">https://x.com/FAA_Chris/status/1938290132525703308</a>

ACHR

JOBY

FAA Acting Administrator Chris Rocheleau Posts On X "It has been thrilling to see advanced air mobility technologies in action. The FAA is working to safely integrate these new aircraft into our nation's airspace while supporting innovation and shaping the future of global aviation.."

Barclays analyst Alex Scott maintains Corebridge Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRBG#NYSE">CRBG</a>) with a Overweight and raises the price target from $38 to $45.

CRBG

Barclays Maintains Overweight on Corebridge Financial, Raises Price Target to $45

BMO Capital analyst Tristan Thomas-Martin maintains Winnebago Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WGO#NYSE">WGO</a>) with a Outperform and lowers the price target from $50 to $42.

BMO Capital Maintains Outperform on Winnebago Industries, Lowers Price Target to $42

<a href="https://www.scmp.com/news/china/science/article/3315999/china-has-begun-issuing-rare-earth-export-licenses-european-firms-eu-sources-say">https://www.scmp.com/news/china/science/article/3315999/china-has-begun-issuing-rare-earth-export-licenses-european-firms-eu-sources-say</a>

Market Vectors Rare Earth/Strategic Metals Etf

REMX

' China has begun issuing rare earth export licenses to European firms, EU sources say'- South China Morning Post

BMO Capital analyst Etienne Ricard maintains Sprott (TSX:<a class="ticker" href="https://www.benzinga.com/stock/SII#TSX">SII</a>) with a Outperform and raises the price target from C$80 to C$94.

TSX:SII

BMO Capital Maintains Outperform on Sprott, Raises Price Target to C$94

Shares of Core Scientific Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) are up Thursday following a report suggesting CoreWeave inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) is in discussions to acquire the <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46102704/coreweave-stock-is-moving-lower-wednesday-whats-going-on">bitcoin mining and hosting company.</a>
What To Know: According to<a href="https://www.wsj.com/business/deals/coreweave-in-talks-to-buy-core-scientific-ed821c09"> the Wall Street Journal</a>, the two companies are in talks and could finalize a deal in the coming weeks if talks proceed without issue. CoreWeave previously made an unsuccessful attempt to acquire Core Scientific about a year ago, offering $5.75 per share at the time; a bid that was rejected for undervaluing the business. Core Scientific shares now trade at more than double that earlier offer, giving the company a market capitalization of roughly $3.7 billion.
Core Scientific operates one of the largest high-powered digital infrastructure platforms in North America focused on bitcoin mining and hosting services. The company has seen growing interest amid a shortage of data center space and power capacity as demand from AI-related workloads continues to rise. It also maintains a significant 12-year hosting partnership with CoreWeave, delivering large-scale capacity for AI computing operations. 
CoreWeave, which went public in March and is valued at approximately $75 billion, specializes in cloud infrastructure for AI workloads. It serves major clients like Microsoft, its largest customer and acts as a middle layer offering access to Nvidia GPUs for firms such as Meta and IBM.
While Core Scientific shares rose on the takeover speculation, CoreWeave's stock slipped slightly reflecting typical market reactions in acquisition scenarios where the buyer faces potential integration or financing challenges.
Price Action: Core scientific shares were up 24% at $15.25 and Coreweave shares were down 1.13% at $157.80 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/06/46115346/trump-powell-fed-chairman-odds-dollar">Trump&#8217;s Fed Chairman Shortlist Is In: What Investors Need To Know</a></li>
</ul>
Image Via Shutterstock.

Movers

Core Scientific, Inc. - Class A Common Stock

CORZ

CRWV

Core Scientific Stock Surges On Acquisition Reports With CoreWeave

BMO Capital analyst Ari Klein downgrades Equinix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQIX#NASDAQ">EQIX</a>) from Outperform to Market Perform and lowers the price target from $1045 to $850.

Downgrades

EQIX

BMO Capital Downgrades Equinix to Market Perform, Lowers Price Target to $850

Wall Street entered full rally mode on Thursday, with the Nasdaq 100 extending its record-setting climb and the S&amp;P 500 approaching its February peak, as easing geopolitical fears and renewed hopes for a dovish Federal <a href="https://www.benzinga.com/topic/federal-reserve">Reserve lifted investor sentiment.</a>
By midday in New York, the S&amp;P 500 was up 0.7% to 6,136, just nine points shy of its all-time high of 6,145. The Nasdaq 100 rose another 0.7% to 22,400, marking yet another intraday record.
Meanwhile, small caps surged, with the Russell 2000 jumping 1%, outperforming the broader market.
On the macro front, the first-quarter GDP was revised downward to -0.5% from the previous -0.2% figure, primarily due to a widening goods trade deficit linked to weaker exports. Yet, other data released Thursday painted a more positive picture.
Factory orders in May soared by 16.4% month-over-month to $343.6 billion, marking the biggest increase since July 2014. That followed a revised 6.6% drop in April and smashed market expectations of an 8.5% gain. Weekly jobless claims fell by 10,000 to 236,000 in the week ending June 21, while economists had forecast no change — another sign of labor market resilience.
Currency markets added fuel to the equity rally. The U.S. dollar index fell to 97, its lowest level since February 2022, as traders increasingly bet that the next Fed chair nominee — with a <a href="https://www.benzinga.com/author/piero-cingari">shortlist reportedly down to four or five names</a> — will favor a dovish stance, potentially setting the stage for deeper rate cuts in 2026.
All S&amp;P 500 sectors traded in the green, except real estate. Energy stocks outperformed, rebounding after sharp down days as crude oil prices rose 2% to $66 per barrel.
Other commodities — especially metals — also rose, fueled by dollar weakness. Silver rose 1.2%, while palladium and <a href="https://www.benzinga.com/markets/commodities/25/06/46120819/platinum-miners-forecasts-stocks">platinum</a> spiked 6.1% and 4.3%, respectively. Copper rose 2.8% hitting a three-month high, while gold held steady at $3,330 per ounce.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) was unchanged at $107,220. 
<h1 class="wp-block-heading">Thursday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices </td>
<td>Price</td>
<td>% Chg</td>
</tr>
<tr>
<td>• Russell 2000</td>
<td>2,158.05</td>
<td>+1.0%</td>
</tr>
<tr>
<td>• Dow Jones</td>
<td>43,355.44</td>
<td>+0.9%</td>
</tr>
<tr>
<td>• Nasdaq 100</td>
<td>22,403.44</td>
<td>+0.7%</td>
</tr>
<tr>
<td>• S&amp;P 500</td>
<td>6,136.45</td>
<td>+0.7%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 1:00 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul class="wp-block-list">
<li>The Vanguard S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>) rose 0.66% to $563.41.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.8% to $433.26.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;soared 0.7% to $544.72.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rallied 1% to $214.05.</li>
<li>The&nbsp;Energy&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, up 1.5%; the&nbsp;Real Estate&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>) lagged, down 0.8%.</li>
</ul>
<h1 class="wp-block-heading">Thursday&#8217;s Stock Movers</h1>
<ul class="wp-block-list">
<li>Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) surged past $155 per share to hit record highs, becoming the world's most valuable company at $3.8 trillion.</li>
<li>Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) slipped 1.1%, even after delivering <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/46121658/micron-impresses-wall-street-with-strong-q3-earnings-continued-strength-in-ai-data-center">stronger-than-expected quarterly earnings</a>.</li>
<li>Other stocks reacting to earnings included Acuity Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>), up 7.1%; McCormick Company Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>), up 5.2% and Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>), up 0.8%.</li>
<li>Freeport-McMoRan Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) jumped 8%, lifted by rising metal prices, with industry peers Southern Copper Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCCO#NYSE">SCCO</a>), Albemarle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>), and Alcoa Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) all rallying between 7% and 8%.</li>
<li>Equinix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQIX#NASDAQ">EQIX</a>) sank 8% after unveiling a long-term growth outlook that underwhelmed investors.</li>
<li>Nike Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) will report earnings after the close. </li>
</ul>
Read Now:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/commodities/25/06/46120819/platinum-miners-forecasts-stocks">Platinum&#8217;s Biggest Rally In 40 Years: These 6 Mining Stocks Could Be Top Gainers </a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Broad U.S. Equity ETFs

Commodities

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

NVDA

SCCO

XLRE

Stocks Rally To New Highs, Dollar Tumbles To 40-Month Lows: What's Driving Markets Thursday?

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Financials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>C</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/25/25</td>
<td>$90.00</td>
<td>$50.5K</td>
<td>174</td>
<td>62.4K</td>
</tr>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/03/25</td>
<td>$380.00</td>
<td>$91.5K</td>
<td>3.6K</td>
<td>6.4K</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$25.00</td>
<td>$52.7K</td>
<td>21.5K</td>
<td>1.2K</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$90.00</td>
<td>$32.6K</td>
<td>2.7K</td>
<td>880</td>
</tr>
<tr>
<td>XYZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$70.00</td>
<td>$99.7K</td>
<td>3.2K</td>
<td>349</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$685.00</td>
<td>$44.8K</td>
<td>153</td>
<td>174</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$90.00</td>
<td>$26.6K</td>
<td>152</td>
<td>131</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$145.00</td>
<td>$47.7K</td>
<td>317</td>
<td>69</td>
</tr>
<tr>
<td>V</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$325.00</td>
<td>$231.8K</td>
<td>45</td>
<td>51</td>
</tr>
<tr>
<td>LMND</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$42.00</td>
<td>$35.2K</td>
<td>35</td>
<td>42</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding C (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), we observe a call option sweep with bullish sentiment. It expires in 29 day(s) on July 25, 2025. Parties traded 500 contract(s) at a $90.00 strike. This particular call needed to be split into 10 different trades to become filled. The total cost received by the writing party (or parties) was $50.5K, with a price of $101.0 per contract. There were 174 open contracts at this strike prior to today, and today 62481 contract(s) were bought and sold. 
• Regarding COIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), we observe a call option trade with bullish sentiment. It expires in 7 day(s) on July 3, 2025. Parties traded 80 contract(s) at a $380.00 strike. The total cost received by the writing party (or parties) was $91.5K, with a price of $1144.0 per contract. There were 3601 open contracts at this strike prior to today, and today 6447 contract(s) were bought and sold. 
• For SOFI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>), we notice a call option sweep that happens to be bullish, expiring in 568 day(s) on January 15, 2027. This event was a transfer of 197 contract(s) at a $25.00 strike. This particular call needed to be split into 14 different trades to become filled. The total cost received by the writing party (or parties) was $52.7K, with a price of $268.0 per contract. There were 21522 open contracts at this strike prior to today, and today 1245 contract(s) were bought and sold. 
• Regarding HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we observe a call option sweep with bullish sentiment. It expires in 113 day(s) on October 17, 2025. Parties traded 31 contract(s) at a $90.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $32.6K, with a price of $1053.0 per contract. There were 2728 open contracts at this strike prior to today, and today 880 contract(s) were bought and sold. 
• For XYZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>), we notice a call option sweep that happens to be bearish, expiring in 204 day(s) on January 16, 2026. This event was a transfer of 134 contract(s) at a $70.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $99.7K, with a price of $744.0 per contract. There were 3286 open contracts at this strike prior to today, and today 349 contract(s) were bought and sold. 
• For GS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), we notice a call option sweep that happens to be bullish, expiring in 22 day(s) on July 18, 2025. This event was a transfer of 20 contract(s) at a $685.00 strike. This particular call needed to be split into 12 different trades to become filled. The total cost received by the writing party (or parties) was $44.8K, with a price of $2240.0 per contract. There were 153 open contracts at this strike prior to today, and today 174 contract(s) were bought and sold. 
• For AFRM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>), we notice a call option trade that happens to be bullish, expiring in 357 day(s) on June 18, 2026. This event was a transfer of 25 contract(s) at a $90.00 strike. The total cost received by the writing party (or parties) was $26.6K, with a price of $1065.0 per contract. There were 152 open contracts at this strike prior to today, and today 131 contract(s) were bought and sold. 
• For MS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), we notice a call option trade that happens to be bearish, expiring in 357 day(s) on June 18, 2026. This event was a transfer of 35 contract(s) at a $145.00 strike. The total cost received by the writing party (or parties) was $47.7K, with a price of $1365.0 per contract. There were 317 open contracts at this strike prior to today, and today 69 contract(s) were bought and sold. 
• For V (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), we notice a call option sweep that happens to be bearish, expiring in 540 day(s) on December 18, 2026. This event was a transfer of 39 contract(s) at a $325.00 strike. This particular call needed to be split into 14 different trades to become filled. The total cost received by the writing party (or parties) was $231.8K, with a price of $5945.0 per contract. There were 45 open contracts at this strike prior to today, and today 51 contract(s) were bought and sold. 
• Regarding LMND (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>), we observe a call option trade with bullish sentiment. It expires in 267 day(s) on March 20, 2026. Parties traded 30 contract(s) at a $42.00 strike. The total cost received by the writing party (or parties) was $35.2K, with a price of $1175.0 per contract. There were 35 open contracts at this strike prior to today, and today 42 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

AFRM

HOOD

LMND

SOFI

10 Financials Stocks Whale Activity In Today's Session

<a href="https://www.youtube.com/watch?v=NKl2dpLylK0">https://www.youtube.com/watch?v=NKl2dpLylK0</a>

White House Says No Imminent Plans For Refilling Strategic Petroleum Reserve

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Consumer Discretionary sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/27/25</td>
<td>$330.00</td>
<td>$35.3K</td>
<td>18.2K</td>
<td>93.8K</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/27/25</td>
<td>$215.00</td>
<td>$43.8K</td>
<td>31.2K</td>
<td>50.2K</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/03/25</td>
<td>$55.00</td>
<td>$96.6K</td>
<td>12.1K</td>
<td>2.9K</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/03/25</td>
<td>$61.00</td>
<td>$31.5K</td>
<td>3.0K</td>
<td>2.1K</td>
</tr>
<tr>
<td>HSAI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$20.00</td>
<td>$29.9K</td>
<td>1.2K</td>
<td>965</td>
</tr>
<tr>
<td>EAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$130.00</td>
<td>$90.1K</td>
<td>3.5K</td>
<td>707</td>
</tr>
<tr>
<td>LI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$27.00</td>
<td>$182.5K</td>
<td>465</td>
<td>607</td>
</tr>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$200.00</td>
<td>$50.7K</td>
<td>212</td>
<td>81</td>
</tr>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$140.00</td>
<td>$37.7K</td>
<td>9</td>
<td>55</td>
</tr>
<tr>
<td>MELI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$2800.00</td>
<td>$940.5K</td>
<td>128</td>
<td>45</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we observe a call option sweep with bearish sentiment. It expires in 1 day(s) on June 27, 2025. Parties traded 101 contract(s) at a $330.00 strike. This particular call needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $35.3K, with a price of $350.0 per contract. There were 18260 open contracts at this strike prior to today, and today 93841 contract(s) were bought and sold. 
• Regarding AMZN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), we observe a call option trade with bearish sentiment. It expires in 1 day(s) on June 27, 2025. Parties traded 200 contract(s) at a $215.00 strike. The total cost received by the writing party (or parties) was $43.8K, with a price of $219.0 per contract. There were 31250 open contracts at this strike prior to today, and today 50224 contract(s) were bought and sold. 
• Regarding CMG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>), we observe a call option sweep with bullish sentiment. It expires in 7 day(s) on July 3, 2025. Parties traded 2597 contract(s) at a $55.00 strike. This particular call needed to be split into 21 different trades to become filled. The total cost received by the writing party (or parties) was $96.6K, with a price of $37.0 per contract. There were 12103 open contracts at this strike prior to today, and today 2949 contract(s) were bought and sold. 
• Regarding NKE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), we observe a put option sweep with bearish sentiment. It expires in 7 day(s) on July 3, 2025. Parties traded 151 contract(s) at a $61.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $31.5K, with a price of $209.0 per contract. There were 3057 open contracts at this strike prior to today, and today 2187 contract(s) were bought and sold. 
• Regarding HSAI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>), we observe a call option sweep with neutral sentiment. It expires in 22 day(s) on July 18, 2025. Parties traded 100 contract(s) at a $20.00 strike. This particular call needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $29.9K, with a price of $299.0 per contract. There were 1224 open contracts at this strike prior to today, and today 965 contract(s) were bought and sold. 
• Regarding EAT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>), we observe a call option sweep with bearish sentiment. It expires in 204 day(s) on January 16, 2026. Parties traded 15 contract(s) at a $130.00 strike. This particular call needed to be split into 11 different trades to become filled. The total cost received by the writing party (or parties) was $90.1K, with a price of $6010.0 per contract. There were 3558 open contracts at this strike prior to today, and today 707 contract(s) were bought and sold. 
• Regarding LI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>), we observe a put option sweep with bullish sentiment. It expires in 267 day(s) on March 20, 2026. Parties traded 500 contract(s) at a $27.00 strike. This particular put needed to be split into 23 different trades to become filled. The total cost received by the writing party (or parties) was $182.5K, with a price of $365.0 per contract. There were 465 open contracts at this strike prior to today, and today 607 contract(s) were bought and sold. 
• For LULU (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>), we notice a call option trade that happens to be neutral, expiring in 204 day(s) on January 16, 2026. This event was a transfer of 10 contract(s) at a $200.00 strike. The total cost received by the writing party (or parties) was $50.7K, with a price of $5075.0 per contract. There were 212 open contracts at this strike prior to today, and today 81 contract(s) were bought and sold. 
• For BABA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), we notice a call option sweep that happens to be neutral, expiring in 568 day(s) on January 15, 2027. This event was a transfer of 25 contract(s) at a $140.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $37.7K, with a price of $1500.0 per contract. There were 9 open contracts at this strike prior to today, and today 55 contract(s) were bought and sold. 
• For MELI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>), we notice a call option trade that happens to be bullish, expiring in 204 day(s) on January 16, 2026. This event was a transfer of 45 contract(s) at a $2800.00 strike. The total cost received by the writing party (or parties) was $940.5K, with a price of $20900.0 per contract. There were 128 open contracts at this strike prior to today, and today 45 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMZN

BABA

HSAI

LULU

MELI

TSLA

10 Consumer Discretionary Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Information Technology sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/27/25</td>
<td>$155.00</td>
<td>$104.4K</td>
<td>109.7K</td>
<td>244.6K</td>
</tr>
<tr>
<td>CORZ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$15.00</td>
<td>$76.6K</td>
<td>22.1K</td>
<td>16.3K</td>
</tr>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$13.00</td>
<td>$157.9K</td>
<td>18.6K</td>
<td>9.5K</td>
</tr>
<tr>
<td>MRVL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/27/25</td>
<td>$75.00</td>
<td>$28.2K</td>
<td>14.1K</td>
<td>8.3K</td>
</tr>
<tr>
<td>INTC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/03/25</td>
<td>$23.00</td>
<td>$106.5K</td>
<td>17.5K</td>
<td>5.7K</td>
</tr>
<tr>
<td>AMD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$155.00</td>
<td>$83.3K</td>
<td>16.1K</td>
<td>3.1K</td>
</tr>
<tr>
<td>CRCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/27/25</td>
<td>$200.00</td>
<td>$63.6K</td>
<td>2.6K</td>
<td>2.1K</td>
</tr>
<tr>
<td>QUBT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/03/25</td>
<td>$17.00</td>
<td>$41.3K</td>
<td>661</td>
<td>975</td>
</tr>
<tr>
<td>AVGO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/27/25</td>
<td>$270.00</td>
<td>$30.6K</td>
<td>566</td>
<td>974</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$230.00</td>
<td>$101.8K</td>
<td>8.2K</td>
<td>706</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• For NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we notice a call option sweep that happens to be bullish, expiring in 1 day(s) on June 27, 2025. This event was a transfer of 567 contract(s) at a $155.00 strike. This particular call needed to be split into 18 different trades to become filled. The total cost received by the writing party (or parties) was $104.4K, with a price of $185.0 per contract. There were 109745 open contracts at this strike prior to today, and today 244656 contract(s) were bought and sold. 
• For CORZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>), we notice a call option trade that happens to be bullish, expiring in 50 day(s) on August 15, 2025. This event was a transfer of 428 contract(s) at a $15.00 strike. The total cost received by the writing party (or parties) was $76.6K, with a price of $179.0 per contract. There were 22190 open contracts at this strike prior to today, and today 16304 contract(s) were bought and sold. 
• For IREN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>), we notice a call option sweep that happens to be bearish, expiring in 22 day(s) on July 18, 2025. This event was a transfer of 1500 contract(s) at a $13.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $157.9K, with a price of $106.0 per contract. There were 18664 open contracts at this strike prior to today, and today 9557 contract(s) were bought and sold. 
• Regarding MRVL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>), we observe a call option sweep with bullish sentiment. It expires in 1 day(s) on June 27, 2025. Parties traded 57 contract(s) at a $75.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $28.2K, with a price of $495.0 per contract. There were 14123 open contracts at this strike prior to today, and today 8316 contract(s) were bought and sold. 
• Regarding INTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>), we observe a call option sweep with bullish sentiment. It expires in 7 day(s) on July 3, 2025. Parties traded 3791 contract(s) at a $23.00 strike. This particular call needed to be split into 30 different trades to become filled. The total cost received by the writing party (or parties) was $106.5K, with a price of $28.0 per contract. There were 17553 open contracts at this strike prior to today, and today 5709 contract(s) were bought and sold. 
• Regarding AMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), we observe a call option sweep with bearish sentiment. It expires in 22 day(s) on July 18, 2025. Parties traded 391 contract(s) at a $155.00 strike. This particular call needed to be split into 35 different trades to become filled. The total cost received by the writing party (or parties) was $83.3K, with a price of $213.0 per contract. There were 16194 open contracts at this strike prior to today, and today 3159 contract(s) were bought and sold. 
• For CRCL (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>), we notice a call option trade that happens to be bearish, expiring in 1 day(s) on June 27, 2025. This event was a transfer of 30 contract(s) at a $200.00 strike. The total cost received by the writing party (or parties) was $63.6K, with a price of $2120.0 per contract. There were 2691 open contracts at this strike prior to today, and today 2148 contract(s) were bought and sold. 
• Regarding QUBT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>), we observe a put option sweep with bullish sentiment. It expires in 7 day(s) on July 3, 2025. Parties traded 516 contract(s) at a $17.00 strike. This particular put needed to be split into 15 different trades to become filled. The total cost received by the writing party (or parties) was $41.3K, with a price of $80.0 per contract. There were 661 open contracts at this strike prior to today, and today 975 contract(s) were bought and sold. 
• For AVGO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), we notice a put option sweep that happens to be bullish, expiring in 1 day(s) on June 27, 2025. This event was a transfer of 120 contract(s) at a $270.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $30.6K, with a price of $255.0 per contract. There were 566 open contracts at this strike prior to today, and today 974 contract(s) were bought and sold. 
• Regarding AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we observe a call option trade with bearish sentiment. It expires in 568 day(s) on January 15, 2027. Parties traded 51 contract(s) at a $230.00 strike. The total cost received by the writing party (or parties) was $101.8K, with a price of $1998.0 per contract. There were 8290 open contracts at this strike prior to today, and today 706 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

AVGO

CRCL

INTC

IREN

MRVL

QUBT

10 Information Technology Stocks Whale Activity In Today's Session

BMO Capital analyst Brian Quast downgrades Ascot Resources (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AOT#TSX">AOT</a>) from Outperform to Market Perform.

TSX:AOT

BMO Capital Downgrades Ascot Resources to Market Perform

<a href="https://techcrunch.com/2025/06/26/rivian-cuts-dozens-on-manufacturing-team-ahead-of-r2-launch/">https://techcrunch.com/2025/06/26/rivian-cuts-dozens-on-manufacturing-team-ahead-of-r2-launch/</a>

RIVN

'Rivian cuts dozens on manufacturing team ahead of R2 launch'- Techcrunch

Press Releases

Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer

Earnings

Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights

Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway

Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Comments

Turnstone Biologics

Noticias

Últimas noticias sobre Turnstone Biologics (NASDAQ:TSBX) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL